Aramark (ARMK)
Last Price$35.91.1%
Market Cap$9,517.2M
ARMK Rating
ARMK Quality rating performance
ARMK Intrinsic Value
Key Highlights:
As of Mar 07, 2025 ARMK Relative Value is $76.9, which is undervalued by 114.0%, compared to current share price of $35.9.
As of Mar 07, 2025 ARMK DCF Value is $8.8, which is overvalued by 75.6%, compared to current share price of $35.9.
ARMK Share Price History
1W (3.0%)
1M (5.4%)
6M (4.4%)
YTD 30.0%
1Y 14.5%
3Y 56.8%
5Y 77.6%
10Y 71.8%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
ARMK Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$9,517.2M
$10.3B
$17.5B
$484.6M
Shares Outstanding
265M
Employees
N/A
Growth (CAGR)
1.6%
(0.3%)
(1.78%)
93.23%
Profitability
7.1%
4.3%
4.5%
2.8%
142.7%
Intrinsic Value
$42.7 (18.7% undervalued)
$8.7
$76.7
$110.0
49.4%
Return on Capital
Financial Health
$759.8M
1.6x
2.3x
40.2%
Dividends
(1.1%)
1.1%
21.2%
Dec 02, 2024
Earnings
Jan 01, 1970
MISS by (0.9%)
BEAT by 1.9%
12.5%
7 Beat & 3 Miss
ARMK Stock Financials
ARMK Income Statement Metrics
Annual
Quarterly
LTM
ARMK Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
$726.5M -5.2% YoY
Capital Expenditure (CAPEX)
$0.0 +4.7% YoY
Free Cash Flow (FCF)
$726.5M -16.5% YoY
ARMK Income Statement Overview
Annual
Quarterly
LTM
Oct'15
Sep'16
Sep'17
Sep'18
Sep'19
Oct'20
Oct'21
Sep'22
Sep'23
Sep'24
$17.4B (7.7%) YoY
Cost of revenue
$16.0B (6.2%) YoY
Pre-tax income
$364.9M (57.1%) YoY
2.1% margin
ARMK Balance Sheet Overview
Annual
Quarterly
LTM
Oct'15
Sep'16
Sep'17
Sep'18
Sep'19
Oct'20
Oct'21
Sep'22
Sep'23
Sep'24
Assets
Liabilities
Total assets
$12.7B
Current assets ($3,406.6M, 26.9% of total)
$714.8M (5.6%)
$2,100.8M (16.6%)
Other current assets
$591.0M (4.7%)
Non-current assets ($9,267.8M, 73.1% of total)
$121.3M (1.0%)
$2,211.9M (17.5%)
$1,949.5M (15.4%)
Other non-current assets
$4,985.1M (39.3%)
Financial position
$4,851.8M
Cash & Short-term
Investments
Total Debt
ARMK Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
ARMK Earnings Surprises
Crunching data... Almost there!
ARMK Dividends
ARMK Dividend Yield
Crunching data... Almost there!
ARMK Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with ARMK
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$9,517.2M | 5.2 | $42.7 18.7% undervalued | 14.5% | $17.5B | $484.6M | (6.0%) | 2.8% | 7.1% | 6.4% | 40.2% | |
$82.8B | 7.6 | $64.3 68.3% overvalued | 30.0% | $9,940.5M | $1,855.0M | 8.1% | 18.7% | 48.8% | 27.1% | 66.3% | |
$77.8B | 6.4 | $106.8 39.9% overvalued | 14.6% | $7,249.2M | $1,849.3M | 5.9% | 25.5% | 32.8% | 18.2% | 25.4% | |
$25.3B | 7.3 | $160.1 58.9% undervalued | (21.2%) | $10.1B | $2,857.8M | 4.7% | 28.3% | 72.2% | 5.6% | 70.6% | |
$18.7B | 7.7 | $80.8 20.3% overvalued | 35.1% | $4,279.2M | $1,001.4M | 15.4% | 23.4% | 56.3% | 5.9% | 73.4% | |
$11.6B | 6.6 | $63.8 178.0% undervalued | (28.5%) | £10.2B | £988.6M | 68.9% | 9.7% | 14.0% | 13.9% | 116.6% | |
$4,251.8M | 5.7 | $128.9 81.1% undervalued | (16.0%) | $5,381.8M | $280.7M | 8.0% | 5.2% | 22.9% | 11.2% | 5.4% | |
$3,894.3M | 5.8 | $155.8 25.6% overvalued | 25.0% | $2,438.7M | $186.4M | 6.7% | 7.6% | 30.8% | 6.7% | 3.2% | |
$3,805.0M | 5.2 | $65.6 9.7% overvalued | (4.6%) | $1,813.5M | $110.8M | 14.0% | 6.1% | 10.1% | 2.5% | 103.0% | |
$3,453.2M | 5.3 | $139.8 155.8% undervalued | 28.5% | $8,359.3M | $167.2M | 3.2% | 2.0% | 34.8% | 3.7% | 81.5% | |
$2,171.4M | 5.2 | $1,369.0 10,162.2% undervalued | (17.0%) | $307.7B | $16.3M | 40,184.5% | 0.0% | 99.9% | (4.1%) | 2.2% |
FAQ
What is Aramark (ARMK) stock rating?
As of today, Aramark has a stock rating of 5 (out of 10), which is considered Good.
is Aramark (ARMK) a good stock to buy?
As of today, Aramark has a Good stock rating, which is 18.7% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 3.2%.